Usefulness of Calprotectin for Colon Adenoma Screening
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2012 by Konkuk University Medical Center.
Recruitment status was Recruiting
Information provided by (Responsible Party):
Chul Min Park, MD, Konkuk University Medical Center
First received: October 30, 2012
Last updated: November 12, 2012
Last verified: November 2012
The fecal calprotectin assay is used widely for inflammatory bowel disease diagnosis and the assessment of the disease activity. Some adenoma patients have elevated fecal calprotectin level, which could mean the role of fecal calprotectin as a screening marker for colon adenoma. We will investigate the usefulness of fecal calprotectin as colon adenoma marker for screening in this study.
||Observational Model: Cohort
Time Perspective: Prospective
||Usefulness of Fecal Calprotectin for Screening Colon Adenoma in Korean Population
Biospecimen Retention: Samples Without DNA
Primary Outcome Measures:
- fecal calprotectin level [ Time Frame: 1 day (at the hospital visit) ] [ Designated as safety issue: No ]
| Estimated Enrollment:
| Study Start Date:
| Estimated Primary Completion Date:
||March 2013 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
patients who visit KUH healthcare center for colonoscopy in Korea over 18 years old adult population
- over 18 years old adult population
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01719198
|Konkuk University Medical Center
|Seoul, Korea, Republic of, 147-729 |
|Contact: Chul Min Park, MD email@example.com |
|Sub-Investigator: Chul Min Park, MD |
Konkuk University Medical Center
||Yeo-Min Yun, MD, PhD
No publications provided
||Chul Min Park, MD, clinical instructor, Konkuk University Medical Center
History of Changes
|Other Study ID Numbers:
|Study First Received:
||October 30, 2012
||November 12, 2012
||Korea: Institutional Review Board
Keywords provided by Konkuk University Medical Center:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on August 27, 2015
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial